Biotech · Private company
Sirtsei Pharmaceuticals, Inc.
Track this companyFree. Adds Sirtsei Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SP-624Phase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- SP-624Phase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major DepressionPHASE1 · COMPLETED · started Aug 22, 2024ClinicalTrials.gov NCT06570369 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderPHASE2 · COMPLETED · started Mar 25, 2024ClinicalTrials.gov NCT06254612 · fetched Nov 12, 2026
- A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With SchizophreniaPHASE1 · COMPLETED · started Oct 15, 2020ClinicalTrials.gov NCT04510298 · fetched Nov 12, 2026
- A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive DisorderPHASE2 · COMPLETED · started Sep 30, 2020ClinicalTrials.gov NCT04479852 · fetched Nov 12, 2026